APA (7th ed.) Citation

Tfelt-Hansen, P., Jørgensen, K., & Diener, H. (2022). Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks. Cephalalgia, 42(1), 82-85. https://doi.org/10.1177/03331024211029939

Chicago Style (17th ed.) Citation

Tfelt-Hansen, Peer, Karsten Jørgensen, and Hans-Christoph Diener. "Doubtful Use of Placebo Following Placebo in Recent Controlled Trials of Lasmiditan and Ubrogepant for the Treatment of Migraine Attacks." Cephalalgia 42, no. 1 (2022): 82-85. https://doi.org/10.1177/03331024211029939.

MLA (9th ed.) Citation

Tfelt-Hansen, Peer, et al. "Doubtful Use of Placebo Following Placebo in Recent Controlled Trials of Lasmiditan and Ubrogepant for the Treatment of Migraine Attacks." Cephalalgia, vol. 42, no. 1, 2022, pp. 82-85, https://doi.org/10.1177/03331024211029939.